IRIS
MACCARI, Rosanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.967
EU - Europa 5.956
AS - Asia 2.698
SA - Sud America 912
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 65
OC - Oceania 7
Totale 15.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.868
RU - Federazione Russa 2.967
SG - Singapore 1.155
CN - Cina 794
BR - Brasile 792
IE - Irlanda 760
SE - Svezia 687
UA - Ucraina 338
HK - Hong Kong 319
DE - Germania 310
IT - Italia 282
FI - Finlandia 149
GB - Regno Unito 140
FR - Francia 137
VN - Vietnam 107
IN - India 77
PL - Polonia 72
CA - Canada 40
BD - Bangladesh 37
AR - Argentina 36
MX - Messico 28
IQ - Iraq 27
AT - Austria 24
TR - Turchia 22
PK - Pakistan 21
MA - Marocco 19
UZ - Uzbekistan 19
EC - Ecuador 17
BE - Belgio 16
VE - Venezuela 16
NL - Olanda 15
CO - Colombia 14
JP - Giappone 14
KE - Kenya 12
ZA - Sudafrica 12
ID - Indonesia 11
CL - Cile 10
CR - Costa Rica 10
ES - Italia 10
IR - Iran 10
MY - Malesia 9
JM - Giamaica 8
PE - Perù 8
SA - Arabia Saudita 8
AU - Australia 7
CZ - Repubblica Ceca 7
LT - Lituania 7
NP - Nepal 7
PY - Paraguay 7
BO - Bolivia 6
IL - Israele 6
PH - Filippine 6
EG - Egitto 5
JO - Giordania 5
KR - Corea 5
OM - Oman 5
PT - Portogallo 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GT - Guatemala 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
RO - Romania 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BN - Brunei Darussalam 2
CG - Congo 2
CH - Svizzera 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BT - Bhutan 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
PA - Panama 1
Totale 15.602
Salva come PNG Salva come JPEG
Città #
Moscow 893
Dublin 760
Ashburn 712
Jacksonville 618
Singapore 608
Chandler 600
Dallas 526
Nyköping 437
Dearborn 390
San Jose 346
Hong Kong 318
Beijing 303
Council Bluffs 203
The Dalles 127
Princeton 120
Los Angeles 118
Medford 116
Cambridge 110
Lauterbourg 99
Ann Arbor 81
Boardman 79
Munich 79
Des Moines 73
Warsaw 67
Buffalo 64
Messina 62
New York 61
São Paulo 52
Ho Chi Minh City 50
Tianjin 39
San Mateo 34
Woodbridge 33
Guangzhou 31
Turku 31
Jinan 30
Wilmington 30
Phoenix 29
Columbus 28
Santa Clara 24
Lancaster 23
Orem 23
Belo Horizonte 22
Seattle 22
Vienna 21
Chennai 19
Denver 19
Rio de Janeiro 19
Frankfurt am Main 18
Houston 18
Brasília 17
Milan 17
Redondo Beach 17
Atlanta 16
Brussels 16
Chicago 15
Haikou 15
Tashkent 15
Hanoi 14
Nanjing 13
Stockholm 13
Curitiba 12
Salvador 12
Shanghai 12
Shenyang 12
Tokyo 12
Washington 12
Boston 11
Hefei 11
London 11
Montreal 11
Shenzhen 11
Taizhou 11
Baghdad 10
Brooklyn 10
Charlotte 10
Düsseldorf 10
Francofonte 10
Hebei 10
Johannesburg 10
Manchester 10
Mumbai 10
San Francisco 10
Taiyuan 10
Campinas 9
Catania 9
Nairobi 9
Naples 9
Pune 9
San José 9
Sorocaba 9
Ardabil 8
Fuzhou 8
Helsinki 8
Mexico City 8
Nanchang 8
Rome 8
Amsterdam 7
Changsha 7
Contagem 7
Dhaka 7
Totale 9.140
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 260
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 212
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 194
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 193
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 191
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 187
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 187
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 184
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 181
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 181
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 180
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 178
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 178
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 176
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 175
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 174
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 173
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 173
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 172
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 172
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 172
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 170
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 170
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 168
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 164
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 164
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 162
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 161
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 157
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 157
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 156
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 154
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 153
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 153
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 152
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 151
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 150
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 149
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 149
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 148
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 146
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 146
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 146
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 146
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 145
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells 143
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 142
(5-Arylidene-2-thioxo-4-oxothiazolidin-3-yl)acetic acids endowed with chondroprotective and matrix metalloproteinase inhibitory activities 138
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 137
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 135
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 132
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 132
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 131
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 131
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 130
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 130
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 130
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 130
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 130
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 130
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 128
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 126
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 126
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 125
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 124
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 124
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 121
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 121
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 119
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 119
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 115
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 115
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 114
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 113
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 113
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 112
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 112
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 112
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 111
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 110
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 110
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 109
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 109
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 108
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 108
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 107
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 107
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 107
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 106
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 105
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 105
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 104
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 103
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 102
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 102
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 102
Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors 95
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 95
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 95
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 95
Totale 14.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.013
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022581 0 0 0 22 43 5 57 24 10 33 125 262
2022/20232.254 161 236 102 217 166 235 63 101 902 10 52 9
2023/2024395 32 78 49 35 46 80 6 20 0 13 2 34
2024/20252.140 21 21 41 135 82 38 57 445 578 128 188 406
2025/20266.734 304 501 483 477 513 1.542 820 841 785 243 127 98
2026/2027816 82 233 354 147 0 0 0 0 0 0 0 0
Totale 15.693